Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019?

被引:2
|
作者
Liu, Di [1 ,2 ]
Li, Yun-Zhao [1 ,2 ]
Wu, Hui [1 ,2 ]
机构
[1] China Three Gorges Univ, Inst Cardiovasc Dis, Yichang, Peoples R China
[2] Yichang Cent Peoples Hosp, Dept Cardiol, Yichang 443003, Hubei, Peoples R China
关键词
D O I
10.1097/HJH.0000000000002474
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:1191 / 1192
页数:3
相关论文
共 50 条
  • [21] Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations Reply
    Bavishi, Chirag
    Whelton, Paul K.
    Mancia, Giuseppe
    Corrao, Giovanni
    Messerli, Franz H.
    JOURNAL OF HYPERTENSION, 2021, 39 (08) : 1726 - 1727
  • [22] ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19)
    Cecilia Lozada, Ma
    Medina, Henry, Jr.
    Fatima Sucaldito, Ma Sergia
    Ella Santos, Lourdes
    Ignacia David-Ona, Deborah
    Oliva, Raymond
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E182 - E182
  • [23] Are Renin-Angiotensin-Aldosterone System Inhibitors Lifesaving in Chronic Kidney Disease?
    Damman, Kevin
    Lambers-Heerspink, Hiddo J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 659 - 660
  • [24] RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HOMEOSTASIS AND DISEASE
    DAVIS, JO
    CLINICAL CHEMISTRY, 1966, 12 (08) : 525 - &
  • [25] Renin-Angiotensin-Aldosterone System Inhibitors in Heart Failure
    Shearer, F.
    Lang, C. C.
    Struthers, A. D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 94 (04) : 459 - 467
  • [26] Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors
    Weir, Matthew R.
    Rolfe, Mark
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (03): : 531 - 548
  • [27] Hyperkalemia and inhibitors of the renin-angiotensin-aldosterone system - Reply
    Palmer, BF
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (23): : 2451 - 2451
  • [28] Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
    Vaduganathan, Muthiah
    Vardeny, Orly
    Michel, Thomas
    McMurray, John J., V
    Pfeffer, Marc A.
    Solomon, Scott D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (17): : 1653 - 1659
  • [29] Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors
    Golpe, Rafael
    Perez-de-Llano, Luis A.
    Dacal, David
    Guerrero-Sande, Hector
    Pombo-Vide, Beatriz
    Ventura-Valcarcel, Pablo
    MEDICINA CLINICA, 2020, 155 (11): : 488 - 490
  • [30] Effect of Renin-Angiotensin-Aldosterone System Inhibitors on the Rupture Risk Among Hypertensive Patients With Intracranial Aneurysms
    Zhong, Ping
    Lu, Zhiwen
    Li, Zhangyu
    Li, Tianxiao
    Lan, Qing
    Liu, Jianmin
    Wang, Zhanxiang
    Chen, Sifang
    Huang, Qinghai
    HYPERTENSION, 2022, 79 (07) : 1475 - 1486